Delivery Order SPE2DB22D3301-SPE2DB25FX4ZN
Award Date
11/5/24
Potential Completion Date
11/27/24
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses, with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,569.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
This is a $1,739.24 Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Pfizer COVID-19 vaccines (0.9ml) during the period of June 2023 to April 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, including a range of 6-month to 4-year doses in 0.9 mL quantities. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award issued by the Defense Logistics Agency (DLA) provides Amerisourcebergen Drug Corp with a Firm Fixed Price Delivery Order for the supply of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 period, with an ultimate completion date of October 10, 2024. The contract has a ceiling value of $1,135.77 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to deliver these critical...
This federal contract award is valued at $56,788.50 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the delivery of Pfizer COVID-19 vaccine doses during the 2024-2025 period, with an ultimate completion date of November 15, 2024. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This is a $5,217.72 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Pfizer COVID-19 vaccine doses (0.9mL) for the 2023-2024 period, under the FDA's Emergency Use Authorization. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2025, which...
This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The $1,129.80 firm fixed-price delivery order has an ultimate completion date of January 13, 2025 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is delivering these COVID-19 vaccines to support military healthcare programs globally through the company's existing...